VeraSci is a company specializing in the development and implementation of innovative clinical trial solutions, particularly in the area of neuroscience. Founded in 2004, the company provides a range of services that include outcome assessment, clinical trial design, and regulatory support aimed at enhancing the efficiency and accuracy of cognitive and behavioral assessments. VeraSci emphasizes its commitment to scientific rigor and data quality, offering both proprietary tools and expert consulting services to support the pharmaceutical and biotech industries in bringing effective treatments to market.